Literature DB >> 28378980

Subthreshold micropulse yellow 577 nm laser therapy of diabetic macular oedema in rural and urban patients of south-eastern Poland.

Małgorzata Latalska1, Agata Prokopiuk2, Dominika Wróbel-Dudzińska3, Jerzy Mackiewicz2.   

Abstract

Objectiv. To evaluate the efficacy of subthreshold micropulse yellow (577 nm) laser photocoagulation in diffuse macular edema (DME) in rural and urban patients of south-eastern Poland. MATERIALS AND
METHOD: Seventy-five eyes of 75 patients with diffuse DME were treated with subthreshold micropulse yellow laser photocoagulation with a 5% duty cycle at an energy level. The laser exposure time was 20 ms and the spot diameter was 100 μm. Best corrected visual acuity (BCVA), reading vision (Snellen) and optical coherence tomography-determined central retinal thickness (CRT) were estimated before and 2, 4 and 6 months after laser treatment. There were no statistically important differences in: the advancement of DME, HbA1c (glycated hemoglobin) level, duration of diabetes mellitus (DM), the degree of vision damage between rural and urban patients.
RESULTS: The follow-up was 6 months later. The baseline BCVA was 0.20 and remained stable- 0.3 after 6 months. The Snellen at baseline was 1.0 and improved to 0.5 finally (p=0.0004). The CRT at baseline was 500 μm and changed to 346 μm (p=0.00000) at the final follow-up. Finally, no retinal damage was observed.
CONCLUSIONS: Place of residence had no statistically significant effect on the demographics data, baseline visual acuity, reading visual acuity and central retinal thickness. Subthreshold micropulse yellow laser showed a highly significant efficiency in the treatment of DME. The effects of the treatment were more significant in rural patients than in urban ones.

Entities:  

Mesh:

Year:  2017        PMID: 28378980     DOI: 10.5604/12321966.1233899

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  4 in total

1.  Optical coherence tomography angiography assessment of 577 nm laser effect on severe non-proliferative diabetic retinopathy with diabetic macular edema.

Authors:  Zi-Jing Li; Jian-Hui Xiao; Peng Zeng; Rui Zeng; Xiang Gao; Yi-Chi Zhang; Yu-Qing Lan
Journal:  Int J Ophthalmol       Date:  2020-08-18       Impact factor: 1.779

2.  Micropulse laser in patients with refractory and treatment-naïve center-involved diabetic macular edema: short terms visual and anatomic outcomes.

Authors:  Diego Alejandro Valera-Cornejo; Marlon García-Roa; Jaime Quiroz-Mendoza; Alejandro Arias-Gómez; Paulina Ramírez-Neria; Yolanda Villalpando-Gómez; Veronica Romero-Morales; Renata García-Franco
Journal:  Ther Adv Ophthalmol       Date:  2021-01-19

3.  Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.

Authors:  Ahmed Hosni Abd Elhamid
Journal:  Open Ophthalmol J       Date:  2017-07-21

4.  Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study.

Authors:  Luisa Frizziero; Andrea Calciati; Tommaso Torresin; Giulia Midena; Raffaele Parrozzani; Elisabetta Pilotto; Edoardo Midena
Journal:  J Pers Med       Date:  2021-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.